7-[2-Deoxy-alpha-L-fucopyranosyl-(1->4)-3-amino-2,3-dideoxy-alpha-L-fucopyranoside]-aklavinone

ID: ALA4799572

PubChem CID: 14696452

Max Phase: Preclinical

Molecular Formula: C34H41NO14

Molecular Weight: 687.70

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@H](C)O3)[C@H](C)O2)c2c(O)c3c(c(O)c2[C@H]1C(=O)OC)C(=O)c1cccc(O)c1C3=O

Standard InChI:  InChI=1S/C34H41NO14/c1-5-34(44)11-18(48-19-9-15(35)32(13(3)47-19)49-20-10-17(37)27(38)12(2)46-20)22-23(26(34)33(43)45-4)31(42)24-25(30(22)41)29(40)21-14(28(24)39)7-6-8-16(21)36/h6-8,12-13,15,17-20,26-27,32,36-38,41-42,44H,5,9-11,35H2,1-4H3/t12-,13-,15-,17-,18-,19-,20-,26-,27+,32+,34+/m0/s1

Standard InChI Key:  YKHJCRMPYWONTM-RRYXKZLTSA-N

Molfile:  

 
     RDKit          2D

 51 56  0  0  0  0  0  0  0  0999 V2000
   29.1713  -14.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1589  -15.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490  -15.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490  -13.9789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5910  -15.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5910  -14.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7350  -15.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8811  -13.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8688  -15.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7391  -14.3916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0190  -14.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2926  -15.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2968  -13.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9406  -16.9051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2101  -17.2725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.0149  -15.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6299  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8540  -18.5354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5886  -18.1598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1730  -18.0855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9819  -16.0838    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490  -13.1659    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490  -16.4553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0251  -15.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8811  -13.1782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8688  -16.4553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.7165  -14.8126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.2737  -18.6097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8086  -19.3567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0251  -13.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0251  -16.4553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4383  -18.4611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3193  -14.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3070  -15.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5910  -16.0467    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   32.5969  -13.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3869  -14.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0794  -19.7256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3978  -19.2762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6710  -19.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6216  -20.4578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3054  -20.9070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0386  -20.5401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9886  -19.1921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8910  -20.8239    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2575  -21.7227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0739  -18.9068    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.2927  -13.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9983  -12.7620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.5829  -12.7691    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.9942  -11.9448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  6  1  0
  6  8  2  0
  7 10  1  0
  8  1  1  0
  9  2  1  0
 10  4  1  0
 11 13  1  0
 12  5  1  0
 13  6  1  0
 14 21  1  1
 15 14  1  0
 16 11  1  0
 17 14  1  0
 18 19  1  0
 19 17  1  0
 20 15  1  0
 21 12  1  0
 22  4  2  0
 23  3  2  0
 24  7  2  0
 25  8  1  0
 26  9  1  0
 11 27  1  6
 19 28  1  6
 18 29  1  6
 30 10  2  0
 31 24  1  0
 20 32  1  6
 33 30  1  0
 34 33  2  0
 12 35  1  1
  5  9  2  0
  7  3  1  0
 16 12  1  0
 24 34  1  0
 18 20  1  0
 11 36  1  0
 36 37  1  0
 29 38  1  0
 38 39  1  0
 38 43  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 40 44  1  6
 41 45  1  6
 42 46  1  6
 38 47  1  6
 13 48  1  1
 48 49  1  0
 48 50  2  0
 49 51  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4799572

   methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-[(2S,4S,5S,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 687.70

Molecular Weight (Monoisotopic): 687.2527

AlogP: 1.14

#Rotatable Bonds: 6

Polar Surface Area: 244.76

Molecular Species: BASE

HBA: 15

HBD: 7

#RO5 Violations: 3

HBA (Lipinski): 15

HBD (Lipinski): 8

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 7.74

CX Basic pKa: 9.91

CX LogP: 2.22

CX LogD: 2.01

Aromatic Rings: 2

Heavy Atoms: 49

QED Weighted: 0.14

Np Likeness Score: 1.62

References

1. Wander DPA,van der Zanden SY,van der Marel GA,Overkleeft HS,Neefjes J,Codée JDC.  (2020)  Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.,  63  (21): [PMID:33064004] [10.1021/acs.jmedchem.0c01191]

Source

Source(1):

• Scientific Literature